Literature DB >> 19887443

Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.

Yoshinori Nishimoto1, Daisuke Ito, Takuya Yagi, Yoshihiro Nihei, Yoshiko Tsunoda, Norihiro Suzuki.   

Abstract

TAR DNA-binding protein-43 (TDP-43) has been recently identified as a major component of the ubiquitinated inclusions found in frontotemporal lobar degeneration with ubiquitin-positive inclusions and in amyotrophic lateral sclerosis, diseases that are collectively termed TDP-43 proteinopathies. Several amyotrophic lateral sclerosis-linked mutations of the TDP-43 gene have also been identified; however, the precise molecular mechanisms underlying the neurodegeneration remain unclear. To investigate the biochemical characteristics of TDP-43, we examined truncation, isoforms, and cytoplasmic inclusion (foci) formation using TDP-43-expressing cells. Under apoptosis, caspase-3 generates two 35-kDa (p35f) and 25-kDa (p25f) fragments. However, in caspase-3(-/-) cells, novel caspase-3-independent isoforms of these two variants (p35iso and p25iso) were also detected under normal conditions. With a deletion mutant series, the critical domains for generating both isoforms were determined and applied to in vitro transcription/translation, revealing alternate in-frame translation start sites downstream of the natural initiation codon. Subcellular localization analysis indicated that p35 (p35f and p35iso) expression leads to the formation of stress granules, cellular structures that package mRNA and RNA-binding proteins during cell stress. After applying proteasome inhibitors, aggresomes, which are aggregates of misfolded proteins, were formed in the cytoplasm of cells expressing p35. Collectively, this study demonstrates that the 35-kDa isoforms of TDP-43 assemble in stress granules, suggesting that TDP-43 plays an important role in translation, stability, and metabolism of mRNA. Our findings provide new biological and pathological insight into the development of TDP-43 proteinopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887443      PMCID: PMC2804209          DOI: 10.1074/jbc.M109.022012

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

Review 2.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

3.  Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells.

Authors:  C L Wellington; R Singaraja; L Ellerby; J Savill; S Roy; B Leavitt; E Cattaneo; A Hackam; A Sharp; N Thornberry; D W Nicholson; D E Bredesen; M R Hayden
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

4.  Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum.

Authors:  L M Mende-Mueller; T Toneff; S R Hwang; M F Chesselet; V Y Hook
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

5.  Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43.

Authors:  Takashi Nonaka; Fuyuki Kametani; Tetsuaki Arai; Haruhiko Akiyama; Masato Hasegawa
Journal:  Hum Mol Genet       Date:  2009-06-10       Impact factor: 6.150

6.  Parkin accumulation in aggresomes due to proteasome impairment.

Authors:  Eunsung Junn; Sang Seop Lee; Unsun T Suhr; M Maral Mouradian
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

7.  Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.

Authors:  J Paul Taylor; Fumiaki Tanaka; Jon Robitschek; C Miguel Sandoval; Addis Taye; Silva Markovic-Plese; Kenneth H Fischbeck
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

8.  Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Authors:  E Buratti; F E Baralle
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

9.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

10.  The RasGAP-associated endoribonuclease G3BP assembles stress granules.

Authors:  Helene Tourrière; Karim Chebli; Latifa Zekri; Brice Courselaud; Jean Marie Blanchard; Edouard Bertrand; Jamal Tazi
Journal:  J Cell Biol       Date:  2003-03-17       Impact factor: 10.539

View more
  60 in total

Review 1.  Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

Review 2.  Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.

Authors:  Daisuke Ito; Norihiro Suzuki
Journal:  Neurology       Date:  2011-09-28       Impact factor: 9.910

3.  Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.

Authors:  Sang Hwa Kim; Naval P Shanware; Michael J Bowler; Randal S Tibbetts
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

4.  The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.

Authors:  Claudia Fallini; Gary J Bassell; Wilfried Rossoll
Journal:  Hum Mol Genet       Date:  2012-05-28       Impact factor: 6.150

5.  Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.

Authors:  J Gavin Daigle; Karthik Krishnamurthy; Nandini Ramesh; Ian Casci; John Monaghan; Kevin McAvoy; Earl W Godfrey; Dianne C Daniel; Edward M Johnson; Zachary Monahan; Frank Shewmaker; Piera Pasinelli; Udai Bhan Pandey
Journal:  Acta Neuropathol       Date:  2016-01-04       Impact factor: 17.088

Review 6.  Amyotrophic lateral sclerosis: an update on recent genetic insights.

Authors:  Yohei Iguchi; Masahisa Katsuno; Kensuke Ikenaka; Shinsuke Ishigaki; Gen Sobue
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

Review 7.  Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.

Authors:  T F Gendron; K A Josephs; L Petrucelli
Journal:  Neuropathol Appl Neurobiol       Date:  2010-02-19       Impact factor: 8.090

Review 8.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

9.  Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis.

Authors:  G Fung; J Shi; H Deng; J Hou; C Wang; A Hong; J Zhang; W Jia; H Luo
Journal:  Cell Death Differ       Date:  2015-05-15       Impact factor: 15.828

10.  A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology.

Authors:  Takenari Yamashita; Takuto Hideyama; Kosuke Hachiga; Sayaka Teramoto; Jiro Takano; Nobuhisa Iwata; Takaomi C Saido; Shin Kwak
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.